O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+11.18%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.5B
AUM Growth
+$9.5B
(+8.1%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
144
New
11
Increased
35
Reduced
32
Closed
10
Top Buys
| 1 |
Cigna
CI
|
$205M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$197M |
| 3 |
Gilead Sciences
GILD
|
$90.1M |
| 4 |
Viatris
VTRS
|
$65.2M |
| 5 |
Biogen
BIIB
|
$52.4M |
Top Sells
| 1 |
Centene
CNC
|
$118M |
| 2 |
HCA Healthcare
HCA
|
$100M |
| 3 |
Pfizer
PFE
|
$99M |
| 4 |
Tenet Healthcare
THC
|
$94.8M |
| 5 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ironwood Pharmaceuticals
IRWD
$214M
| $109M | 1.14% | 5,759,200 -1,482,100 | -20% | -$28M |
|
|
ICPT
27
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $104M | 1.09% | 856,554 -180,446 | -17% | -$21.8M |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $96.3M | 1.01% | 1,831,647 +335,647 | +22% | +$17.6M |
|
|
SGYP
29
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $94.1M | 0.99% | 21,153,343 | – | – |
|
30
Ascendis Pharma
ASND
$11.8B
| $93.5M | 0.98% | 3,367,315 +650,000 | +24% | +$18M |
|
31
Thermo Fisher Scientific
TMO
$186B
| $93.2M | 0.98% | 534,200 | – | – |
|
|
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
| $91.9M | 0.96% | 4,801,638 | – | – |
|
|
AGN
33
DELISTED
Allergan plc
AGN
| $90.8M | 0.95% | 373,590 -103,800 | -22% | -$25.2M |
|
|
SHPG
34
DELISTED
Shire pic
SHPG
| $90.7M | 0.95% | 548,808 -348,643 | -39% | -$57.6M |
|
35
BioMarin Pharmaceuticals
BMRN
$11.2B
| $89.2M | 0.94% | 982,600 -291,500 | -23% | -$26.5M |
|
|
MGLN
36
DELISTED
Magellan Health Services, Inc.
MGLN
| $88.6M | 0.93% | 1,215,100 +126,373 | +12% | +$9.21M |
|
37
Jazz Pharmaceuticals
JAZZ
$7.75B
| $84.9M | 0.89% | 545,900 +174,500 | +47% | +$27.1M |
|
|
38
Pfizer
PFE
$141B
| $82.6M | 0.87% | 2,458,800 -2,947,300 | -55% | -$99M |
|
39
UnitedHealth
UNH
$281B
| $79.5M | 0.83% | 428,600 +132,200 | +45% | +$24.5M |
|
|
INSY
40
DELISTED
Insys Therapeutics, Inc.
INSY
| $78.1M | 0.82% | 6,171,440 +100,000 | +2% | +$1.27M |
|
41
Medtronic
MDT
$119B
| $78M | 0.82% | 879,000 +112,400 | +15% | +$9.98M |
|
|
AGN.PRA
42
DELISTED
Allergan plc.
AGN.PRA
| – | – | -88,200 | Closed | -$74.8M |
|
43
Insmed
INSM
$28.8B
| $75.4M | 0.79% | 4,393,509 -417,396 | -9% | -$7.16M |
|
44
Glaukos
GKOS
$5.5B
| $72.2M | 0.76% | 1,741,700 | – | – |
|
45
Illumina
ILMN
$15.8B
| $69.1M | 0.72% | 398,500 +76,600 | +24% | +$13.3M |
|
|
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $66M | 0.69% | 1,472,700 | – | – |
|
47
Corvus Pharmaceuticals
CRVS
$428M
| $65.1M | 0.68% | 5,379,349 | – | – |
|
|
VRAY
48
DELISTED
ViewRay, Inc.
VRAY
| $61.2M | 0.64% | 9,458,567 | – | – |
|
|
ACHN
49
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $60.2M | 0.63% | 13,107,200 | – | – |
|
|
GBT
50
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $59.4M | 0.62% | 2,171,935 +1,087,435 | +100% | +$29.7M |
|